Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.
Nos
Pilar
P
Bastida
Guillermo
G
Beltran
Belen
B
Aguas
Mariam
M
Ponce
Julio
J
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017074:Common Variable Immunodeficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003424:Crohn Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab